1.Introduction to Viral Vectors and Other Delivery Methods for Gene Therapy of the Nervous System Frederic P. Manfredsson
Part II Expression Cassettes
2. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors Matthew L. Hirsch, Sonya J. Wolfe, and R. J. Samulski
3. Expression of Multiple Functional RNAs or Proteins from One Viral Vector Tomas Björklund
4. Regulated Gene Therapy Ludivine Breger, Erika Elgstrand Wettergren, Luis Quintino, and Cecilia Lundberg
5. Design of shRNA and miRNA for Delivery to the CNS Gabriela Toro and Christian Mueller
6. Tissue Specific Promoters in the CNS Sebastian Kügler
Part III Viral Vector Production
7. Small Scale Recombinant Adeno-Associated Virus Purification Corinna Burger and Kevin Nash
8. Lentivirus Production and Purification Matthew J. Benskey and Frederic P. Manfredsson
9. Viral Vector Production: Adenovirus Julius W. Kim, Ramin A. Morshed, J. Robert Kane, Brenda Auffinger, Jian Qiao, and Maciej S. Lesniak
Part IV Viral Vector Tropism
10. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids Michael J. Castle, Heikki T. Turunen, Luk H. Vandenberghe, and John H. Wolfe
11. Altering Tropism of rAAV by Directed Evolution Damien Marsic and Sergei Zolotukhin
12. Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins Kenta Kobayashi, Shigeki Kato, Ken0ichi Inoue, Masahiko Takada, and Kazuto Kobayashi
13. Directed Evolution of Adenoviruses Jason G. Smith
Part V Delivery Methods
14. Intraparenchymal Stereotaxic Delivery of rAAV and Special Considerations in Vector Handling Matthew J. Benskey and Frederic P. Manfredsson
15. MRI-Guided Delivery of Viral Vectors Ernesto A. Salegio, John Bringas, Krystof S. Bankiewicz
16. Systemic Gene Therapy for Targeting the CNS Sara E. Gombash and Kevin D. Foust
17. Widespread Neuronal Transduction of the Rodent CNS via Neonatal Viral Injection Ji-Yoen Kim, Stacy D. Grunke, and Joanna L. Jankowsky
18. AAV-Mediated Gene Transfer to Dorsal Root Ganglion Hongwei Yu, Gregory Fischer, and Quinn H. Hogan
19. Gene Therapy of the Peripheral Nervous System: The Enteric Nervous System Matthew J. Benskey and Frederic P. Manfredsson
20. Gene Therapy of the Peripheral Nervous System: Celiac Ganglia
21. Convection Enhanced Delivery of Recombinant Adeno-Associated Virus into the Mouse Brain Kevin R. Nash and Marcia N. Gordon
22. Non-Viral Gene Therapy of the Nervous System: Electroporation XueFeng Ding and Ming Fan
23. Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection James G. Hecker
24. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model Masatoshi Suzuki and Clive N. Svendsen
Part VI Gene-Therapy Based Modeling of Neurodegenerative Disorders
25. Gene Therapy Models of Alzheimer’s Disease and Other Dementias Benjamin Combs, Andrew Kneynsberg, and Nicholas M. Kanaan
26. Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson’s Disease D. Luke Fischer, Sara E. Gombash, Christopher J. Kemp, Frederic P. Manfredsson, Nicole K. Polinski, Megan F. Duffy, and Caryl E. Sortwell
27. Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington's Disease Deborah Young
Part VII Gene-Therapy for the Treatment of Neurological Disorders
28. Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis Zachary T. Mceachin, Anthony Donsante, and Nicholas Boulis
29. Stereotaxic Surgical Targeting of the Non-Human Primate Causate and Putamen: Gene Therapy for Huntington’s Disease Jodi L. McBride and Randall L. Clark
30. Gene-Therapy for the Treatment of Neurological Disorders: Metabolic Disorders Dominic J. Gessler and Guangping Gao
31. Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms Neha Kamran, Marianela Candolfi, Gregory J. Baker, Mariela Moreno Ayala, Marta Dzaman, Pedro R. Lowenstein, and Maria G. Castro
Part VIII Clinical Trials
32. AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned? Jeffrey H. Kordower
Fredric P. Manfredsson, Ph.D. Assistant Professor Michigan State University Division of Translational Science & Molecular Medicine Van Andel Institute 333 Bostwick Ave NE Grand Rapids, MI 49503 Tel: 616-234-0968 Fax: 616-234-0990
This volume provides a clear and detailed roadmap of how to design and execute a gene therapy experiment in order to obtain consistent results. Chapters in this book disseminate bits of unknown information that are important to consider during the course of experimentation and will answer questions such as: What delivery vehicle do you use?; How will you ensure that your vector retains stability?; What expression system best fits your needs?; What route will you choose to deliver your gene therapy agent?; How will you model the neurodegenerative disorder that you aim to investigate, and what are the proven methods to treat these disorders in preclinical models? Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and thorough, Gene Therapy for Neurological Disorders: Methods and Protocols, is a compilation of protocols and instructive chapters intended to give researchers, clinicians, and students of all levels, a foundation upon which future gene therapy experiments can be designed.